利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

122 条记录 (耗时 0.052 秒)

    Adaptive scheduler for communication systems apparatus, system and method
    81.
    发明授权
    Adaptive scheduler for communication systems apparatus, system and method 有权
    通信系统装置，系统和方法的自适应调度器

    公开(公告)号：US08462791B2

    公开(公告)日：2013-06-11

    申请号：US12936694

    申请日：2008-05-22

    申请人： Feng Jiang

    发明人： Feng Jiang

    IPC分类号： H04L12/28 ,  H04L12/56

    CPC分类号： H04L47/10 ,  H04L45/60 ,  H04L47/20 ,  H04L47/2408 ,  H04L47/2441 ,  H04L47/34

    摘要： An apparatus, system, and method may include adaptively scheduling packet processing modules by ordering the packet processing modules based on at least one of traffic composition and computational complexity of the packet processing modules. The apparatus, system and method may analyze at least one of traffic composition information derived from at least one packet data stream and computational complexity information pertaining to packet processing modules, determine an ordering of the packet processing modules based on the analyzing, wherein packets are passed through the packet processing modules until the packet meets criteria associated with a packet processing module or the packet has been passed through all of the packet processing modules, and dynamically rearrange the packet processing modules into the determined ordering.

    摘要翻译： 装置，系统和方法可以包括通过基于分组处理模块的业务组合和计算复杂度中的至少一个来排序分组处理模块来自适应地调度分组处理模块。 装置，系统和方法可以分析从至少一个分组数据流导出的业务组合信息和与分组处理模块有关的计算复杂性信息中的至少一个，基于分析确定分组处理模块的排序，其中分组被传递 通过分组处理模块，直到分组满足与分组处理模块相关联的标准或分组已经通过所有分组处理模块，并且将分组处理模块动态地重新排列成确定的顺序。

    METHOD FOR MANAGING TREATMENT OF A PARTICULAR HEALTH CONDITION VIA A MOBILE PHONE DEVICE
    82.
    发明申请
    METHOD FOR MANAGING TREATMENT OF A PARTICULAR HEALTH CONDITION VIA A MOBILE PHONE DEVICE 有权
    通过移动电话设备管理特殊健康状况的治疗方法

    公开(公告)号：US20130012797A1

    公开(公告)日：2013-01-10

    申请号：US13612732

    申请日：2012-09-12

    申请人： Steven Drucker ,  Charles T. Liamos ,  Fredric C. Colman ,  Mark Lortz ,  Kelley Lipman ,  Feng Jiang ,  Henrik Bacho

    发明人： Steven Drucker ,  Charles T. Liamos ,  Fredric C. Colman ,  Mark Lortz ,  Kelley Lipman ,  Feng Jiang ,  Henrik Bacho

    IPC分类号： A61B5/145

    CPC分类号： G06F19/3418 ,  A61B5/14532 ,  A61B5/742 ,  A61B5/743 ,  A61B2562/0295 ,  G01N33/48778 ,  G01N33/48792 ,  G06F19/00 ,  G06Q50/22 ,  G06Q50/24 ,  G16H40/63 ,  Y10S435/97

    摘要： A method for managing treatment of a particular health condition afflicting a patient through the use of a mobile phone device which includes a health management program stored in the mobile phone device that prompts a user for entry of health condition data, including patient physiological data, subjective patient health condition data, and medication delivery data, compiles the health condition data into an accumulated data summary, and transmits the data summary from the mobile phone device to a second processing unit through a communication port. A drop-down list related to subjective symptoms is provided, which includes stress and depression. A touch screen is provided for a graphical user interface. The health management program also provides prompts for the entry of diet data, and further displays drop-down lists related to daily activities and alerts for medication delivery.

    摘要翻译： 一种用于管理通过使用移动电话设备来治疗患有病人的特定健康状况的方法，该移动电话设备包括存储在移动电话设备中的健康管理程序，其提示用户输入健康状况数据，包括患者生理数据，主观 患者健康状况数据和药物输送数据，将健康状况数据编译为累积数据摘要，并通过通信端口将数据摘要从移动电话设备发送到第二处理单元。 提供与主观症状相关的下拉列表，其中包括压力和抑郁。 为图形用户界面提供触摸屏。 卫生管理方案还提供进入饮食数据的提示，并进一步显示与日常活动相关的下拉列表和用于药物输送的警报。

    TIVOZANIB RESPONSE PREDICTION
    83.
    发明申请
    TIVOZANIB RESPONSE PREDICTION 审中-公开
    TIVOZANIB反应预测

    公开(公告)号：US20120231478A1

    公开(公告)日：2012-09-13

    申请号：US13502476

    申请日：2010-06-03

    申请人： Jie Lin ,  Bin Feng ,  Murray Robinson ,  Feng Jiang ,  Xiaojian Sun

    发明人： Jie Lin ,  Bin Feng ,  Murray Robinson ,  Feng Jiang ,  Xiaojian Sun

    IPC分类号： G01N33/566

    CPC分类号： G01N33/57492 ,  C12Q1/6886 ,  G01N33/57407 ,  G01N2333/70596 ,  G01N2800/52

    摘要： A diagnostic method for predicting whether a human tumor will be sensitive or resistant to treatment with tivozanib (AV-951) is disclosed. The method is based on measurement of macrophage content in a tissue sample from a tumor. Measurement of macrophage content can be based on analysis of macrophage marker gene expression, e.g., by RNA analysis or immunohistochemistry.

    摘要翻译： 公开了一种诊断方法，用于预测人肿瘤是否敏感或对利托那尼治疗有抗药性（AV-951）。 该方法基于来自肿瘤的组织样品中巨噬细胞含量的测量。 巨噬细胞含量的测定可以基于巨噬细胞标记基因表达的分析，例如通过RNA分析或免疫组织化学。

    Detection and diagnosis of smoking related cancers
    84.
    发明授权
    Detection and diagnosis of smoking related cancers 有权
    检测和诊断吸烟相关的癌症

    公开(公告)号：US08093001B2

    公开(公告)日：2012-01-10

    申请号：US12761134

    申请日：2010-04-15

    申请人： Ruth Katz ,  Feng Jiang

    发明人： Ruth Katz ,  Feng Jiang

    IPC分类号： C07H21/04 ,  C12Q1/68

    CPC分类号： C12Q1/6886 ,  C12Q2600/118

    摘要： Gene probes for specific regions of chromosome 3 (3p21.3) and chromosome 10 (10q22) have been found to be tools for the diagnosis and prognosis of smoking related cancers such as non-small cell lung cancer (NSCLC). For example, these probes can be used with fluorescence in situ hybridization (FISH), and used to stratify smokers into high and low risk groups, as well as determine a patients susceptibility to the development of smoking related cancers.

    摘要翻译： 已经发现染色体3（3p21.3）和染色体10（10q22）的特定区域的基因探针是用于诊断和预测与非小细胞肺癌（NSCLC）相关的吸烟相关癌症的工具。 例如，这些探针可以与荧光原位杂交（FISH）一起使用，并用于将吸烟者分为高危组和低危组，以及确定患者对吸烟相关癌症发展的易感性。

    Detection and Diagnosis of Smoking Related Cancers
    88.
    发明申请
    Detection and Diagnosis of Smoking Related Cancers 有权
    吸烟相关癌症的检测与诊断

    公开(公告)号：US20100240060A1

    公开(公告)日：2010-09-23

    申请号：US12761134

    申请日：2010-04-15

    申请人： Ruth Katz ,  Feng Jiang

    发明人： Ruth Katz ,  Feng Jiang

    IPC分类号： C12Q1/68

    CPC分类号： C12Q1/6886 ,  C12Q2600/118

    摘要： Gene probes for specific regions of chromosome 3 (3p21.3) and chromosome 10 (10q22) have been found to be tools for the diagnosis and prognosis of smoking related cancers such as non-small cell lung cancer (NSCLC). For example, these probes can be used with fluorescence in situ hybridization (FISH), and used to stratify smokers into high and low risk groups, as well as determine a patients susceptibility to the development of smoking related cancers.

    摘要翻译： 已经发现染色体3（3p21.3）和染色体10（10q22）的特定区域的基因探针是用于诊断和预测与非小细胞肺癌（NSCLC）相关的吸烟相关癌症的工具。 例如，这些探针可以与荧光原位杂交（FISH）一起使用，并用于将吸烟者分为高危组和低危组，以及确定患者对吸烟相关癌症发展的易感性。

    DETECTION AND DIAGNOSIS OF SMOKING RELATED CANCERS
    90.
    发明申请
    DETECTION AND DIAGNOSIS OF SMOKING RELATED CANCERS 审中-公开
    吸烟相关癌症的检测和诊断

    公开(公告)号：US20070218480A1

    公开(公告)日：2007-09-20

    申请号：US11627253

    申请日：2007-01-25

    申请人： Ruth Katz ,  Feng Jiang

    发明人： Ruth Katz ,  Feng Jiang

    IPC分类号： C12Q1/68

    CPC分类号： C12Q1/6886 ,  C12Q2600/106 ,  C12Q2600/112 ,  C12Q2600/118

    摘要： Gene probes for specific regions of chromosomes 1, 3, 9, 10 and 17 are now shown to be useful in the diagnosis and prognosis of smoking related cancers such as non-small cell lung cancer (NSCLC). For example, these probes can be used with fluorescence in situ hybridization (FISH), and used to stratify smokers into high and low risk groups, to determine susceptibility to the development of smoking related cancers, to predict cancer progression and treatment efficacy, and to rule out other diseases.

    摘要翻译： 染色体1,3,9,10和17的特定区域的基因探针现在显示可用于与非小细胞肺癌（NSCLC）相关的吸烟相关癌症的诊断和预后。 例如，这些探针可以与荧光原位杂交（FISH）一起使用，并用于将吸烟者分为高危组和低危组，以确定吸烟相关癌症发展的易感性，预测癌症进展和治疗效果，以及 排除其他疾病。